Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer

International Journal of Colorectal Disease

Volumn 22, Issue 2, 2007, Pages 127-136

  Schwandner, O ^a,b   Schlamp, A ^a   Broll, R ^a   Bruch, H P ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b CARITAS KRANKENHAUS ST JOSEF   (Germany)

Author keywords

Immunohistochemistry; Matrix metalloproteinases; Metastasis; Prognosis; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FORMALDEHYDE; GELATINASE A; MATRILYSIN; MATRIX METALLOPROTEINASE 14; PARAFFIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER STAGING; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EPITHELIUM CELL; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RECTUM CANCER; RECTUM CARCINOMA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; STROMA CELL; TISSUE SECTION; TUMOR GROWTH; TUMOR RECURRENCE; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 33845699864     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0173-y     Document Type: Article

References (34)

1. Basset P, Okada A, Chenard M-P, Kannan R, Stoll I, Anglard P, Bellocq J-P, Rio M-C (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutical implications. Matrix Biol 15:535-541
2. Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792
3. Bruch HP, Schwandner O, Keller R, Farke S, Schiedeck THK (2003) Surgical therapy for rectal cancer. Chirurg 74:905-914
4. Bruch HP, Schwandner O, Schiedeck THK, Roblick UJ (1999) Actual standards and controversies on operative technique and lymph-node dissection in colorectal cancer. Langenbecks Arch Surg 384:167-175
5. Bruch HP, Schwandner O (2002) Totale mesorektale Exzision beim Rektumkarzinom: Das Dissektionsprinzip ohne kontrollierte Daten. Viszeralchirurgie 37:6-11
6. Wexner SD, Rotholtz NA (2000) Surgeon-influenced variables in resectional rectal cancer surgery. Dis Colon Rectum 43:1606-1627
7. Hermanek P (1999) Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 42:559-562
8. Köckerling F, Reymond MA, Altendorf-Hofmann A, Dworak O, Hohenberger W (1998) Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 16:324-329
9. Talvensaari-Mattila A, Paakko P, Hoyhtya M, Blanco-Sequeiros G, Turpeenniemi-Hujanen T (1998) Matrix metalloproteinase-2 immunoreactive protein: A marker of aggressiveness in breast carcinoma. Cancer 83:1153-1162
10. Westerlund A, Apaja-Sarkkinen M, Hoyhtya M, Puistola U, Turpeenniemi-Hujanen T (1999) Gelatinase A-immunoreactive protein in ovarian lesions - prognostic value in epithelial ovarian cancer. Gynecol Oncol 75:91-98
11. Grigioni WF, D'Errico A, Fortunato C, Fiorentino M, Mancini AM, Stetler-Stevenson WG et al (1994) Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 7:220-225
12. Miyajima Y, Nakano R, Morimatsu M (1995) Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104:678-684
13. Walther MM, Kleiner DE, Lubensky IA, Pozzatti R, Nyguen T, Gnarra JR et al (1997) Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival. Urology 50:295-301
14. D'Errico A, Garbisa S, Liotta LA et al (1991) Augmentation of type IV collagenase, laminin receptor, and Ki-67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4:239-246
15. Tomita T, Iwata K (1996) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 39:1255-1264
16. Kikuchi R, Noguchi T, Takeno S, Kubo N, Uchida Y (2000) Immunohistochemical detection of membrane-type-1-matrixmetalloproteinase in colorectal carcinoma. Br J Cancer 83:215-218
17. Masaki T, Sugiyama M, Matsuoka H, Abe N, Izumisato Y, Sakamoto A, Atomi Y (2003) Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas. Anticancer Res 23:4169-4173
18. Sato H, Seiki M (1996) Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis. J Biochem 119:209-215
19. Ring P, Johansson K, Hoyhtya M, Rubin K, Lindmark G (1997) Expression of tissue inhibitor of metalloproteinase TIMP-2 in human colorectal cancer - a predictor of tumour stage. Br J Cancer 76:805-811
20. Sis B, Sagol O, Kupelioglu A, Sokmen S, Terzi C, Fuzun M, Ozer E, Bishop P (2004) Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma. Pathol Res Pract 200:379-387
21. Malhotra S, Newman E, Eisenberg D, Scholes J, Wieczorek R, Mignatti P, Shamamian P (2002) Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: A possible mechanism of neoplastic progression. Dis Colon Rectum 45:537-4322
22. Bendardaf R, Lamlum H, Vihinen P, Ristamaki R, Laine J, Pyrhonen S (2003) Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma. Oncology 65:337-346
23. Joo YE, Seo KS, Kim J, Kim HS, Rew JS, Park CS, Kim SJ (1999) Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. J Korean Med Sci 14:417-423
24. Li BH, Zhao P, Liu SZ, Yu YM, Han M, Wen JK (2005) Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis. World J Gastroenterol 11:3046-3050
25. Murashige M, Miyahara M, Shiraishi N, Saito T, Kohno K, Kobayashi M (1996) Enhanced expression of tissue inhibitors of metalloproteinases in human colorectal tumors. Jpn J Clin Oncol 26:303-309
26. Adachi Y, Yamamoto H, Itoh F, Arimura Y, Nishi M, Endo T, Imai K (2001)Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 20:290-294
27. Adachi Y, Yamamoto H, Itoh F, Hinoda Y, Okada Y, Imai K (1999) Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut 45:252-258
28. Masaki T, Matsuoka H, Sugiyama M, Abe N, Goto A, Sakamoto A, Atomi Y (2001) Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer 84:1317-1321
29. Luo HZ, Zhou ZG, Yang L, Yu YY, Tian C, Zhou B, Zheng XL, Xia QJ, Li Y, Wang R (2005) Clinicopathologic and prognostic significance of MMP-7 (matrilysin) expression in human rectal cancer. Jpn J Clin Oncol 35:739-744
30. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S (2004) Simultaneous determination of matrix metalloproteinases (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19:518-524
31. Kurokawa S, Arimura Y, Yamamoto H, Adachi Y, Endo T, Sato T, Suga T, Hosokawa M, Shinomura Y, Imai K (2005) Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers. Gut 54:1751-1758
32. Malhotra S, Newman E, Eisenberg D, Scholes J, Wieczorek R, Mignatti P, Shamamian P (2002) Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer: A possible mechanism of neoplastic progression. Dis Colon Rectum 45:537-543
33. Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R (2005) Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal cancer carcinoma tissue samples. Anticancer Res 25:3387-3391
34. Langenskiold M, Holmdahl L, Falk P, Ivarsson ML (2005) Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Int J Colorectal Dis 20:245-2552